By Haley Weiss — 2019
A study on rats offers the first biological evidence that small doses of hallucinogenic drugs could have therapeutic benefits.
Read on www.theatlantic.com
CLEAR ALL
Once considered the quintessential party drug, MDMA (also known as “ecstasy,” “X,” or “molly”) is now experiencing a surge of interest in a completely different area: psychedelic-assisted psychotherapy.
LSD, or lysergic acid diethylamide, is a synthetic drug with potent psychedelic properties. Commonly known as acid, it was originally derived from compounds found in ergot, a fungus that grows on rye.
The mind-altering drug has been shown to help people suffering from anxiety and depression. But how it helps, who it will serve, and who will profit are open questions.
1
In the deep space of the psychedelic experience exists a teaching on unity principle and belonging with the earth.
As Western medicine brings psychedelics into mainstream use, a growing movement is innovating new business models grounded in reciprocity and inclusion.
The psychedelic revolution has arrived—yet psychologists still have major gaps in knowledge about going on a shrooms trip in the name of mental health.
Many people have a spiritual experience on psychedelics. How they make meaning of it could be influenced by the metaphysical beliefs of their therapists.
Could there be one factor that links together conflict, climate change, racism, anxiety and eating disorders?
Society has started to become more accepting of our work and MAPS’ goal of mainstreaming psychedelic medicine seems closer than ever to being achieved,” explains MAPS Policy and Advocacy Director Natalie Ginsberg, M.S.W., in an interview with Jessica Semaan of Seismic Sisters.
Consuming crumb-size amounts of psychedelics — not to get high but to feel more focused and creative and present — has moved a tiny bit mainstream.
3